A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis

Clinical trial NCT00295282 · COMPLETED

Trial details

NCT number: NCT00295282
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2006-01-01
Primary completion: 2008-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.